Introduction
The simplest definition of beer is a fermented and flavored drink derived from starch [1] . This simple definition encompasses essentially the four essential ingredients, which are used in the brewing industry: barley (malt), hop, water and yeast. Brewing beer is a complex process that allows variation in multiple parameters which influence the type and quality of beer. These include the variety/type of barley and the malting process, temperature and pH during mashing, sparging, boiling, the variety of hops added during wort boiling, and yeast fermentation.
Beer is a very rich source of carbohydrates, amino acids, minerals, vitamins, and phenolic compounds derived from hop and malt, and thus may have some health benefits [2] .
Research has been conducted to identify the health benefits of beer, particularly in terms of prevention of lifestyle-related diseases such as sickness caused by unsuitable dietary habits, such as the lack of exercise or stress. The diseases include type-2 diabetes, osteoporosis, coronary heart disease, neurodegenerative disorders (dementia, Alzheimer, Parkinson), hypertension, atherosclerosis, and many types of cancer.
This article summarizes the most important results of several studies on the health benefits of xanthohumol (XN), a natural compound present in beer and hop. Recent research on hops has examined the biological activities of single hop components, especially XN. Anti-inflammatory, antioxidant, anti-lipoperoxidative activities as well as antiangiogenic, antiproliferative and apoptotic effects, mainly assessed in vitro studies, reasonably suggest a potential chemopreventive activity [3, 4] . In addition, XN displays broad-spectrum anti-infective activity against several micro-organisms [5] . Based on the health-promoting properties of XN, the production of an enriched beer in this substance would be of huge interest to the brewing industry. In this review the most important and recent data about the production of XN-enriched hop extracts and XN-enriched beers are presented. 
Brewing process
There are some important aspects of the brewing process that must be known in order to a better understand the behavior of XN during beer production. The fundamental processes of brewing (mashing, boiling, fermentation, maturation, filtration and bottling), are illustrated in Figure 1 , and briefly explained in this section. [7] [8] [9] : Brewing begins with malted barley that is milled and mixed with hot water to form a mash. During this step, the malt starches are converted to sugars. The sugar rich water is then strained through the bottom of the mash and is now called wort. The wort then goes to the brew kettle where it is brought to a boil. During this stage, hops are added at different times during the boil for either bitterness or aroma. The wort is then cooled and aerated, and the yeast is added for fermentation. The yeast produces alcohol and carbon dioxide and other byproducts from the sweet wort. After fermentation the "green beer" undergoes maturation. The last step in the brewing process is filtration, and then carbonation. The beer is next moved to a holding tank where it stays until it is bottled. [7] [8] [9] : Mashing, by definition, is the process whereby ground malt, or grist, is mixed with brewing water (liquor) such that a fermentable extract is produced that will support yeast growth, with the subsequent production of beer.
The overall process

Mashing
Mashing involves mixing milled malt and solid adjuncts with water at a set temperature and volume to continue the biochemical changes initiated during the malting process. The mashing process is conducted over a period of time at various temperatures in order to activate the enzymes responsible for the acidulation of the mash and the reduction in amount of proteins and carbohydrates.
The most important change brought about in mashing is the conversion of starch molecules into fermentable sugars and unfermentable dextrins. The principal enzymes responsible for starch conversion are αand β-amylases but also proteases, leading to a mixture of sugars and peptides or amino acids. Together, αand β-amylase are capable of converting only 60 to 80% of the available starch to fermentable sugars.
The entire mash is transferred by gravity or pump to either a lauter tun or a mash filter where the liquid wort is separated from the mash solids. One of the advantages of mash filters is the better recovery of extract due to the finer grist used, compared to that used by the lauter tun. Additionally, using mash filters, wort separation can be achieved in less than an hour, while lautering typically takes up to two hours to be achieved. [7] [8] [9] : Following extraction of the carbohydrates, proteins, and yeast nutrients from the mash, the clear wort must be conditioned by boiling in the kettle. After filtration, the wort is transferred to the brewing kettle, where it is boiled during at least one hour with the addition of hops. The purpose of wort boiling is to stabilize the wort and extract the desirable components from the hops. The principal changes that occur during wort boiling are as follow: sterilization, destruction of enzymes, formation of insoluble complexes with proteins and polypeptides (hot trub), color development, isomerization (especially of the socalled α-acids to β-acids, that are responsible for the typical bitterness of beer), dissipation of volatile constituents, concentration and oxidation. [7] [8] [9] : At the end of the boiling period, the hopped wort is transferred to a vessel known as a whirlpool, where further separation of hop debris and the trubaceous matter (hot break) takes place. After boiling and clarification, the wort leaving the whirlpool has to be cooled in preparation for the addition of yeast and subsequent fermentation. Wort is usually cooled through plate heat exchangers. The principal changes that occur during wort cooling are as follow: cooling the wort to yeast pitching temperature, formation and separation of cold break and oxygenation of the wort to support yeast growth. [7] [8] [9] : Fermentation, by definition, is the process by which fermentable carbohydrates are converted by yeast into alcohol, carbon dioxide, and numerous byproducts. These byproducts have a considerable effect on the taste, aroma, and other characteristic properties of the beer. Fermentation is dependent upon the composition of the wort, the yeast, and fermentation conditions. Wort composition, as discussed previously, influences fermentation by the presence and concentration of various nutrients, pH, and degree of aeration and temperature. These factors can affect the rate of fermentation, the extent of fermentation, the amount of yeast produced, and the quality of beer produced. Depending on the temperature during fermentation and the nature of yeast collection at the end of the fermentation period, beers are distinguished as being produced by 'bottom fermentation' or 'top fermentation'. Yeast strains, appropriate for bottomfermented beers (Saccharomyces uvarum), are active below 5ºC and they settle to the bottom of the fermentation vessel after production of about 5% ethanol. Conversely, top-fermented beers are produced with Saccharomyces cerevisiae at ambient temperature and resistant to higher concentrations of ethanol (up to 12%). When the activity stops, the yeast cells collect at the top as dense foam. [7] [8] [9] : Traditionally, maturation involves secondary fermentation of the remaining fermentable extract at a reduced rate controlled by low temperatures and a low yeast count in the green beer. During secondary fermentation, the remaining yeast becomes re-suspended utilizing the fermentable carbohydrates in the beer. The carbohydrates can come from the residual gravity in the green beer or by addition of priming sugar or by kraeusening. Yeast activity achieves carbonation, purges undesirable volatiles, removes of all residual oxygen, and chemically reduces many compounds, thus leading to improved flavor and aroma. [7] [8] [9] : A final filtration is needed to remove residual yeast, other turbiditycausing materials, and microorganisms in order to achieve colloidal and microbiological stability. If there is a significant quantity of suspended material to be removed, powder filters using diatomaceous earth or perlite must be employed.
Wort boiling
Wort clarification and cooling
Beer fermentation
Beer maturation
Beer filtration
To achieve beer stability it is necessary to remove the proteins, polyphenols, or both from the beer. These haze precursors can be removed during the cold conditioning or filtration steps, i.e., during colloidal stabilization at the filter. During filtration, the most commonly used stabilizer for removing proteins is amorphous silica gel. Polyvinylpolypyrolidone (PVPP) is typically used for removing polyphenols. The major process after filtration and prior to packaging is carbonation. Carbon dioxide not only contributes to perceived "fullness" or "body" and enhances foaming potential, but it also acts as a flavor enhancer and plays an important role in extending the shelf life of the product. [7] [8] [9] : Once the final quality of the beer has been achieved, it is ready for packaging. The packaging of beer is one of the most complex aspects of brewery operations and the most labor intensive of the entire production process. It is probably one of the most critical steps in beer flavor stability. Filling the bottle from the bottom reduces turbulence and oxygen ingress. Brewers usually slightly overcarbonate the beer for any loss of carbon dioxide during the filling operation.
Bottling and pasteurization
The basis for pasteurization is the heating of the beer for a predetermined period of time at specific temperatures, thereby assuring the microbiological stability of the beer. The two main types of pasteurization techniques are flash and tunnel. Flash pasteurization is used for continuous treatment of bulk beer prior to filling the bottles, cans, or kegs. It is typically carried out in a plate heat-exchanger before transferring the beer to the bright-beer tank. Tunnel pasteurization is used mainly for in-pack treatment following the crowning of the bottles. The bottles are loaded at one end of the pasteurizer and passed under sprays of water as they move along the conveyor. The sprays are so arranged that the bottles are subjected to increasingly hot water until the pasteurization temperature (usually 60ºC) is reached. The bottles are then gradually cooled with water until they are discharged from the end of the pasteurizer. Passage through the tunnel pasteurizer takes about one hour.
Beer chemistry
Beer has been a popular beverage for thousands of years, and brewers often describe brewing as the oldest biotechnology process. Beer contains more than 800 compounds and many of them contribute to its flavor characteristics, such as bitterness, sweetness, acidity, hop character, carbonation, alcoholic and fruity or ester flavor [1, 2, 10] . Some of the constituents of this beverage are derived from the raw materials and remain unchanged after the brewing process. Others are the result of chemical and biochemical transformation of the raw materials by the brewing process. Beer constituents can be divided into volatile and non-volatile components [11] . A great number of volatiles have been identified in beer such as alcohols, carbonyl compounds, esters, amines, hydrocarbons, organic acids, and sulfur compounds. These compounds have greater vapour pressure and are responsible for the bouquet or aroma that normally characterizes the beer [10, 11] . Some volatiles are present in extremely small quantities, while others are found in comparatively high concentrations. Some of them are of great importance and may contribute greatly to the beer flavor, while others are important only in building up the background flavor of the beverage [1, 10] . However, the taste and flavor of the beer also depends on the contents of chloride, sulfate, carbonate, and magnesium, while iron, lead, copper, zinc, and tin may all cause haze formation in beer [1, 2] . The non-volatile constituents of beer include inorganic compounds, carbohydrates, amino acids, amines, minerals, vitamins, polyphenols and hop resins together with macromolecules such as polysaccharides, proteins and nucleic acids [11] . Without making an exhaustive survey of the chemicals in beer, some examples are shown in Tables 1 and 2.
Xanthohumol in beer and hops
The hop plant (Humulus lupulus L.) is a widely cultivated plant of the Cannabacea family, grown especially for its secondary metabolites (among them mostly the so-called α− and β-acids) [ Table 2 ] which are used in brewing to add bitterness and aroma to beer [22] . As previously discussed, the plant has been used in the brewing industry to add bitterness and aroma to beer [23, 24] .
Most of the hop polyphenols are made up of higher molecular weight compounds such as the flavonol type tannins. Only about 20% of the hop polyphenols consist of low molecular substances like catechin or proanthocyanidins, phenolic carbon acids (e.g. ferulic acid) and flavonols (quercetin, kaempferol) which are glycosidically bound to various sugars [25] . Even resveratrol could be detected in hops, but at very low concentrations [26] . Furthermore, some polyphenols are almost exclusive to hops. Each plant has a typical polyphenolic pattern and hops prove to be a rich source of prenylated polyphenols (prenylflavonoids). Hops are the only source of prenylflavonoids in beer, which are secreted along with bitter acids and essential oils by the lupulin glands of the inflorescences ( Figure 2 ) [23] . XN is the main prenylflavonoid of hops (0.2-1.1%, w/w). In the hop resin, the yellow compound (Greek: xantho = yellow) is accompanied by at least 13 related chalcones, all of which occur at 10-100 fold lower concentrations relative to XN [27] . The content of XN depends mainly on the cultivar in question and the climate during growth [22, 28] . XN also occurs in the Chinese medicinal plant Sophora flavescens [29] . XN is largely converted into its isomeric flavanone, isoxanthohumol (IXN), during wort boiling [20, 23, 30, 31] (Figure 3 ), which has a conspicuously better solubility, even though its biological effects are less promising [3, 30, 31] . In general, this is the main reason why commercial beers around the world are characterized by a very low content of XN (maximum of 0.15 mg/L in conventional pale beers) and a high content of IXN (ranging from 0.04 to 3.44 mg/L) [21] .
However, there are other factors responsible for the low content of XN. Large quantities of XN are removed during wort production together with the trub. Losses can be explained by the hydrophobic character of XN and the insufficient extraction of XN in wort [23, 32] . During fermentation and filtration, XN content decreases further. The impact of yeast is not yet clear. The decrease of the XN content during primary and secondary fermentation may be due to adsorption of XN on the yeast cells [ However, the lower XN concentration in a filtrated beer sample after addition of yeast and saturation of the yeast by reuse, supports this hypothesis [6] .
Further studies on yeast are needed to get more information about metabolism. Probably the saturation effect is caused by reduced yeast vitality and metabolism [6] . Losses by decomposition of XN are also possible. The fact that IXN is less influenced by yeast may be due to differences in solubility [6] .
Beer stabilization, especially with PVPP (polyvinylpolypyrrolidone), is associated with a strong reduction of XN in beer, due to the high affinity of adsorption of this compound on the polymer [23, 32] . 
Producing XN-enriched hop extracts and XN-enriched beers
XN-enriched hop extracts:
Since hops are the only source of prenylflavonoids in beer, it is not surprising that there is a relationship between hopping rate or the origin of the hop extract and the prenylflavonoid content in beer [21] . Hops, beyond their natural form, can be found as pellets and extracts. The use of pellets is much more recent than the use of extracts but its fast acceptance has made it the dominant form of hops since 1975 [24] . The ethanolic and the supercritical CO 2 extracts of hops are important and useful in the beer industry [24] .
Polyphenols are typically concentrated in the leaves of the hop cone and have polar, hot water-soluble properties [24] . Thus, it is not surprising that polyphenols cannot be extracted with non-polar solvents such as CO 2 or hexane. Whereas after common extraction of hops with carbon dioxide (<300bar) all polyphenols including prenylflavonoids remain in the spent hops, these components are extracted with ethanol [24] . The absence or low content of prenylflavonoids in beer, especially XN and IXN, is due to the use of CO 2 extracts in the brewing process to add the bitterness to the beer [21, 24] . This is a very common procedure applied by many brewers.
In recent years, brewers are making efforts to produce XN-enriched hop extracts [23, [30] [31] [32] [33] [34] [35] , since this is the only means to increase the XN content in beer to a measurable amount. As previously discussed, XN is extracted from the pure resin with ethanol whereas it is not extracted by super critical carbon dioxide (<300 bar). XN can therefore be separated from the α-acids by combining these industrial scale processes [35] .
As an example, the process of production of an XNenriched hop product used by Hopsteiner will be described [35] . The starting material for common ethanol extraction are whole hops which are extracted with a 90% fermentation alcohol and water solvent in a counter-current extractor. After the hops have passed through the extractor, they leave the extraction as spent material. The solution of ethanol and dissolved hop material is pumped to a multi-step vacuum evaporation system where the solvent is removed. The resultant raw extract can be separated into a so-called pure resin extract and a so-called tannin extract by means of centrifugation. The tannin extract consists of approximately 50% water and water soluble components like mineral salts, carbohydrates, proteins and polyphenols. In contrast, hop essential oils and hop resins are completely recovered in the pure resin extract. Due to their chemical structure (the prenyl side chain reduces the polarity), the prenylflavonoids are the only class of polyphenols not present in the tannin extract but in the pure resin extract. The average recovery of XN in this process is approximately 95%.
xanthohumol isoxanthohumol
For the enrichment of prenylflavonoids, pure resin extract is at first re-extracted with supercritical carbon dioxide (50ºC, 280 bar) in order to remove the so-called α and β-acids and other non-specific soft resins, while all the hard resins and the prenylflavonoids remain in the extraction residue ("Xantho-Extract") which consists of hard resins and prenylflavonoids (5-20% XN depending on hop variety). A selective separation of prenylflavonoids from resins is possible with the use of PVPP. When an ethanolic solution of "Xantho-Extract" is mixed with PVPP, the prenylflavonoids are adsorbed, and can later be eluted by ethyl acetate. After evaporation of the organic solvent under vacuum, the product obtained is a yellow power ("Xantho-Flav") consisting of only prenylflavonoids with XN as the main component (65-85%). By a further recrystallization step it is possible to get "Xantho-Pure" with a XN content of approximately 95% [35] .
XN-enriched beers:
The previously reported beneficial health effects associated with hops and beer have attracted attention in the brewing community concerning the production of XNenriched beers. As previously discussed, various brewing studies have been carried out using XNenriched hop products. Stettner et al. [33] and Biendl et al. [31] used a hop extract produced by ethanol extraction followed by supercritical CO 2 extraction. Beers obtained were high in IXN content (up to 8.6 mg/L), but only residues of XN (< 0.1mg/L) could be found. The use of higher XN-enriched hop products (30-90%) did not increase the XN recovery in conventionally produced filtrated beers [36] . To overcome the water insolubility of XN-enriched hop products, the addition of a food grade emulsifier is suggested [35] . Since a XN dosage prior to filtration also leads to high losses, Forster et al. [36] recommend the XN dosage after filtration to minimize costs. However this procedure is limited to XN solubility in Pilsner beer of 3 mg/L and does not conform to the German purity law of beer, which allows only the addition of hop extracts to hot wort [6] .
As one of the first steps for XN enrichment in beer, "XAN" technology was developed by Back et al. [32] and by Wünderlich et al. [6] . The main aspects of this technology will improve the utilization rate of XN during the brewing process ( Figure 4 ). Using this "XAN" technology, an XN content of about 1-3 mg/L can be achieved for unfiltered lager beers and up to 10 mg/L for filtered dark beers [6] . Wünderlich et al. [6] published the effects of dark, roasted substances on the XN content in beer. A study of special malts and cereals showed that the roasting process generated substances, which can inhibit XN isomerization during wort boiling and increase the XN yield. In this study it was verified that brews with more intensive roasted malts, like roasted malt type II and roasted malt beer, had higher XN contents than those with less intensive roasted malts [6] .
Recently, Magalhães et al. [23] investigated the influence of an XN-enriched hop product on the content of XN and IXN in pale and dark beers during the whole brewing process. As expected, it was verified that XN was mainly converted into IXN during wort boiling in Pilsner brewing trials. However, the use of dark malts revealed a positive effect on the thermal isomerization of XN. These results are indicative of the isomerization-inhibiting effect of the stout production process, which resulted in notable high levels of XN in the beer. Presumably, XN is bound to the roasted substances, present in roasted malt and black malt extract, during wort boiling preventing isomerization, as previously discussed by Wünderlich [6, 32] . The roasted substances may act as a carrier and transport XN throughout the brewing process. Recently published papers have revealed that the use of small quantities of roasted malt improved XN solubility and its recovery [6, 34, 35] .
Magalhães et al. [23] report that it was possible to produce a dark beer enriched in XN (3.5 mg/L) by using colored malt (caramel malt, roasted malt and roasted malt extract) and a special XN hop extract combined with late hop usage during wort boiling [23] . With respect to the sensorial evaluation, the tasting panel could differentiate the stout brewed with the XN product from the control beer. The quality of the bitterness was placed as somewhat higher and described as more harmonic [23] . In recent published papers it was observed that the addition of XN positively influenced the bitterness in beer (finer, more harmonic) [30, 33] .
In 2004 the Bavarian State Brewery Weihenstephan introduced into the market two new beverages based on Weissbeer, with elevated levels of XN: "XAN Hefeweissbeer" and "XAN Wellness", a non-alcoholic beer-based drink. XAN Hefeweissbeer contains 1.4 mg/L of XN, about 15 times more than a normal Hefeweissbeer and "XAN Wellness" contains approximately 4 mg/L of XN [34] . "XAN Weissbeer" constitutes a real beer innovation in the context of the German Purity Law. This beer is characterized by an alcohol content of 5.1% (v/v) and excellent head retention. A special hop extract contributes a definite bitterness (22 EBU units) which harmonizes perfectly with the fruity aroma of the Hefeweissbeer (banana, clove) [34] . On the other hand, "XAN Wellness" (0.05 vol% alcohol), the first soft drink on the German market with XN, consists of 40% of an alcohol-free malted hops drink and 60% of a multi-fruit drink and is produced without any preservatives. It has a pleasant fruity-fresh taste and harmonious ratio of sweet and sour constituents [34] .
As it is produced with pure fruit sugar, it is also suitable for nutrition as part of a dietary plan.
"XAN Wellness" contains several substances that the human body needs every day to remain healthy: vitamins, minerals and trace elements. In addition to folic acid (vitamin B 9 ), which plays an essential role in all growth and development processes, and vitamin C, this beverage also contains potassium, calcium and magnesium.
Beer and health
Beer, a low-alcohol beverage, is the most consumed type of alcohol in the world [37] . Nowadays, it is accepted that indiscriminate consumption of beer, as other alcoholic beverages, can be harmful and dangerous to the human health. Among the several injurious effects of alcohol, the most important are: dysfunctions of digestive system (e.g. hepatitis, fatty degeneration of liver, cirrhosis, pancreatitis, peptic ulcer) [38] [39] [40] , cancer (e.g. mouth, pharynx, larynx, breast, liver, colon) [41] [42] [43] , dysfunctions of nervous system (cerebral, cerebellar, brain stem degeneration; optic atrophy, polyneuropathy) [44] [45] [46] , hypertension [47, 48] , and myopathy [49] . However, in several studies it has been demonstrated that the light-tomoderate consumption of alcoholic beverages, especially beer, is associated with the prevention of several lifestyle-related diseases, such as type-2 diabetes [50] [51] [52] [53] , osteoporosis [27, 37, 54, 55] , coronary heart disease [56] [57] [58] [59] [60] [61] , hypertension [62] , neurodegenerative disorders (dementia, Alzheimer, Parkinson) [63] [64] [65] [66] [67] , atherosclerosis [68] [69] [70] [71] [72] [73] [74] , and many types of cancer [4, 37, [75] [76] [77] [78] [79] [80] [81] [82] . Indeed, beer contains components that are associated with positive impacts on the body (antioxidants, minerals, vitamins, fibre, as well as relatively low levels of ethanol). For that reason, brewers probably don't need to improve this composition, but might do more to position their products as part of an overall healthy and balanced diet. However, fortification of beer with some bioactive/healthy components (e.g. XN) can enhance the functional properties that beer presents naturally.
It seems that beer is, at least, similar to the wine in respect to the potential benefits that it can bring for consumer's health, when consumed in moderation. Innes (1998) [83] suggested that beer should replace red wine as the cardioprotective beverage of choice.
In agreement with this author, the effectiveness, low cost, acceptable adverse-event profile and the fact that it is available in convenient single-dose dispensers are the main key for the replacement of red wine for beer [83] . However, more future studies should be conducted to evaluate fully the favorable features of beer consumption.
In recent years several studies about antioxidants, especially phenolic compounds from beer and brewing raw materials, have been conducted. Due to their characteristics and antioxidant properties, the phenolic compounds actually have an important role in nutrition and human health. Several studies demonstrated that the flavonoids, one of the most important classes of polyphenols, have a protective effect on the cardiovascular system, beside their manifest antiviral and antiallergic properties. As previously said, among these substances, special attention has been given to XN. Various notable biological activities (mainly assessed in vitro) of this compound have been reported in recent years. As shown in Table 3 , XN has significant antioxidative and anti-inflammatory activities. It has also been shown to be an effective antiproliferative and cancer chemopreventive agent in human cancer cell lines. It has also been reported to be a strong diacylglycerol acyltransferase inhibitor against obesity and atherosclerosis ( Table 3 ). In addition, this compound proved to possess a broad-spectrum anti-infective (antibacterial, antiviral, antifungal, and antimalarial) activity against several microorganisms (Table 3) .
Xanthohumol and Health
Antioxidant activity and lifestyle-related diseases (e.g. obesity and atherosclerosis):
Atherosclerosis, the pathological basis of coronary artery disease (CAD) and ischemic stroke, is a common cause of death in the Western countries. It is now acknowledged that atherosclerosis is a chronic pathogenic inflammatory-fibro-proliferative process of large and medium-sized arteries that results in the progressive formation of fibrous plaques, which in turn impair the blood flow of the vessel. These injuries can either promote an occlusive thrombosis in the affected artery or produce a gradual but relentless stenosis of the arterial lumen. In the first case, an infarction of the organ supplied by the afflicted vessel occurs, such as in a heart attack, when a coronary artery is affected, and in a thrombotic stroke when a cerebral artery is suddenly blocked. In the second case, the stenosis of the vessel leads to a progressive and gradual damage of the affected organ part [142, 143] .
Reactive oxygen and nitrogen species are thought to play a role in the development of cancer and neurodegenerative diseases such as atherosclerosis [27, 84] . Scavenging of these reactive species (e.g. hydroxyl, peroxyl, and superoxide anion radicals) represents one of the possible mechanisms by which flavonoids exert antioxidant activities [27] . Scavenging of reactive species by XN and IXN was investigated by Gerhäuser et al. [3] . This investigation showed that XN was 8.9-and 2.9-fold more potent that the reference compound trolox at a concentration of 1 mM with respect to scavenging of hydroxyl and peroxyl radicals in the ORAC (oxygen radical absorbance capacity) assay [3] . XN was also a potent scavenger of superoxide anion radicals, generated by xanthine oxidase, without directly inhibiting xanthine oxidase activity [3] .
The reactive species may cause oxidative modification of low density lipoproteins (LDL), which is often associated with the initiation of atherosclerosis [84, 85, 143] . The lipid peroxidation caused by free radicals has been implicated in the pathogenesis of atherosclerosis, and others diseases such as cancer, neurologic disorders and toxic damage of cells [68, 143] . Evidence suggests that the peroxidation of LDL is a relevant event in the formation of an atheroma, a phenomenon known as the "oxidation theory of atherogenesis", thus supporting the physiopathological role of vascular free radicals. The participation of reactive oxygen species in the process of atherogenesis occurs through the superoxide radical, that not only oxidizes the LDL fraction of cholesterol but also reacts quickly with nitric oxide producing peroxynitrite, an extremely aggressive radical, also capable of directly oxidizing LDL [109] . Therefore, by decreasing the bioavailability of nitric oxide, the endothelium looses the antiatherogenic protective effects of nitric oxide, by the loss of its vasodilator action and by the loss of the capacity to inhibit plaquetary activation and aggregation, as well as the proliferation of flatmuscular cells -relevant factors in the appearance, development and aggravation of atherosclerosis.
Prenylchalcones and prenylflavonones from hops and beer were examined for their capacity to inhibit the oxidation of LDL in vitro [85] . At concentrations of 5 and 25 μM, all of the prenylchalcones tested inhibited Biological and/or pharmacological activity Ref.
Antioxidant activity [27, 68, 84, 85, 86, 87, 88] Antiproliferative/ anticarcinogenic activity [3, 4, 27, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114] Antigenotoxic activity [99, 115] Anti-inflammatory activity [97, 116, 117] Diacylglycerol acyltransferase (DGAT) inhibition [92, 118, 119, 120, 121, 122] Antiangiogenic activity [97, 123, 124, 125, 126, 127] Antibacterial activity [5, 97, 117, 128, 129, 130, 131, 132, 133] Antiviral activity [5, 97, 117, 134, 135, 136, 137] Antifungal activity [5, 97, 117, 138] Antimalarial activity [5, 97, 117, 139, 140, 141] the oxidation of LDL. XN showed high antioxidant activity in inhibiting LDL oxidation, higher than αtocopherol and the isoflavone genistein but lower than the flavonol quercetin. These findings suggest that prenylchalcones found in hops and beer are able to protect human LDL from oxidation [85] . A similar study by Stevens et al. [84] , showed that prenylated chalcones (e.g. XN) and to a lesser extent their nonprenylated and flavanone analogues (e.g. IXN) inhibit peroxynitrite-mediated oxidation of LDL at low micromolar concentrations.
Recently, Rodriguez et al. [68] studied the influence of prenylated and non-prenylated flavonoids on liver microsomal lipid peroxidation. Specifically, prenylated chalcones from hops and beer were compared with non-prenylated flavonoids (chalconaringenin, naringenin, genistein and quercetin) for their ability to inhibit lipid peroxidation in rat liver microsomes. Chalcones with prenyl-(e.g. XN) or geranyl-groups, at 5 and 25 μM, were more effective inhibitors of microsomal lipid peroxidation than chalconaringenin, naringenin or genistein induced by Fe 2+ /ascorbate. Prenylated chalcones were effective inhibitors of microsomal lipid peroxidation induced by Fe 3+ -ADP/NADPH and by tert-butyl hydroperoxide (TBH) but to a lesser extent than the Fe 2+ /ascorbate system. Based on the inhibition of lipid peroxidation in rat liver microsomes induced by Fe 2+ /ascorbate, Fe 3+ -ADP/NADPH, or TBH, it can be concluded that, at 25 μM, prenylchalcones such as xanthohumol may have important antioxidant activities [68] . These results provide additional information that prenylation represents a crucial structural modification of xanthohumol that will influence chemopreventive potential.
Diacylglycerol acyltransferase (DGAT) catalyses the transfer of an acyl residue from acyl-CoA to diacylglycerol (DG) to form a triglyceride or triacylglycerol (TG) [121, 122] . Excessive accumulation of TG in certain organs and tissues of the body causes high risk conditions of fatty liver, obesity, and hypertriglyceridemia, leading to atherosclerosis, diabetes, metabolic disorders and functional depression of some organs [118, 119, 121, 122, 144] . DGAT is exclusively involved in TG formation and thus is expected to be an effective target of inhibition for the treatment and prevention of these diseases. In a study realized by Tabata et al. [118] , a methanolic extract of hop plants showed inhibitory activity against rat liver DGAT.
From DGAT inhibitory activity-guided fractionation, two chalcones were isolated (XN and XN B) . These compounds showed preferential inhibition of TG formation on intact Raji cells, indicating that they inhibit DGAT activity preferentially in living cells [118] . As XN inhibits DGAT, and consequently reduces the accumulation of TG, this compound can lower the risk of atherosclerosis [145] .
Although the study by Tabata et al. [118] was crucial in identifying chalcones as potential DGAT inhibitors, these experiments did not provide any insights into how XN and DGAT inhibition might regulate hepatic apolipoprotein B (apoB) secretion. Because TG availability is a major factor in the regulation of apoB secretion, Casaschi et al. [120] examined the effects of XN on apoB and TG synthesis and secretion using a human hepatoma cellline HepG2, as the model system. The present study indicated that XN inhibited apoB secretion in a dosedependent manner under both basal and lipid-rich conditions. XN enhanced apoB degradation due to a lack of lipidation of the lipoprotein particle caused by insufficient transfer of newly synthesized TG from the microsomal membrane to the active luminal pool via DGAT and MTP (microsomal triglyceride transfer protein) activity. In conclusion, the data suggested that XN is a potent inhibitor of apoB secretion. This study contributed to a better understanding of the role of this chalcone in the treatment of hypertriglyceridemia [120] .
Vinson et al. [69] studied the effect of two types of beer on an animal model of atherosclerosis. In this work, a dark beer and a lager beer were given at two different concentrations to cholesterol-fed hamsters, an animal model of atherosclerosis. At the high dose (1/2 diluted beer) both beers significantly inhibited atherosclerosis compared to a control of 2% alcohol. At this dose, the lager significantly decreased cholesterol and triglycerides, and both beers acted as in vivo antioxidants by decreasing the oxidizability of LDL. At the lower concentration (1/10 diluted beer) only the lager significantly decreased atherosclerosis compared to the control (0.4% alcohol). The authors of this study suggested that the polyphenols present in the beers appear to be the main agents responsible for the benefits of beer in this model.
Obesity is a complex disorder with multiple causes including both genetic and environmental factors. For that reason, the prevention and treatment of obesity are critical to shorten the rising incidence of morbidity and mortality [122, 146] . Potential therapeutic agents, especially from natural products, that have the ability to inhibit adipogenesis or increase cell death by apoptosis could be important tools in preventing obesity [122, 146] . Recently, Yang et al. [144] studied the effect of XN and IXN on 3T3-L1 cell apoptosis and adipogenesis. In this study, adipocytes were treated with several concentrations of XN and IXN. In mature adipocytes both XN and IXN decreased viability, increased apoptosis and increased ROS generation. However, XN was more effective than IXN. On the other hand, both XN and IXN decreased adipogenesis during the differentiation period, XN being the most potent. In addition, Yang et al. [147] studied the effects of XN and honokiol (HK), a lignan isolated from Magnolia officinalis, alone and in combination, on apoptosis in 3T3-L1 adipocytes. Combinations of XN and HK significantly decreased viability, induced apoptosis in a dose-dependent manner and more than the additive responses to XN and HK alone. Based on these studies, the authors suggested that the prenylated flavonoids from hops and beer would inhibit adipogenesis and induce apoptosis in adipocytes, making them potentially useful as antiobesity agents [144, 147] .
Anti-infective activity (antibacterial, antiviral, antifungal, antimalarial):
As previously discussed, XN has the capacity to act as a potent anti-infective agent, as well as to inhibit the replication of selected microorganisms including bacteria, viruses, fungi and malarial protozoa. This section briefly summarizes some of the more recent and important reports about these anti-infective activities.
Antimalarial activity:
Malaria is one of the most common infectious diseases and an enormous public health problem. The disease is caused by protozoan parasites of the genus Plasmodium. Only four species of the Plasmodium parasite can infect humans. However, the most serious forms of the disease are caused by Plasmodium falciparum and Plasmodium vivax [117] . P. falciparum is responsible for most deaths, with more than 280 million people infected worldwide and more than one million deaths annually [5, 117] .
When blood stages of the malarial parasite P. falciparum enter human erythrocytes, they feed from enzymatic (by aspartyl and cysteine proteases) degradation of haemoglobin [5, 139] . Haemoglobin is ingested from the host cell and digested inside the parasite's food vacuole. The by-product of this digestion is the toxic haemin, which is detoxified by forming an insoluble polymer (malaria pigment) [139] . An alternative haemin detoxification mechanism has been described [140] . Nonpolymerized haemin exits the food vacuole into the parasite's cytosol, where it is degraded by glutathione (GSH) [140] .
The most commonly used antimalarial drug is chloroquine [5, 139] . Unfortunately, the emergence of drug-resistant strains has reduced its efficacy, and there is an urgent need for the identification of potent, novel and cost-effective inhibitors [5, 117] . Chalcones (e.g. XN) are among the structural classes for which antiplasmodial/antimalarial activity has been reported [5] great interest in scientific community in recent years.
Herath et al. [141] studied the antimalarial activity of metabolites of XN against D6 (chloroquine-sensitive) and W2 (chloroquine-resistant) strains of the malaria parasite, P. falciparum. The activity of plasmodial lactate dehydrogenase (LDH) was determined as an indicator of the number of parasites remaining in infected red blood cells (RBC's), following incubation with samples. XN as well as a microbial transformation product were active against both strains, with IC 50 values of 3.3 μg/mL and 4.1 μg/mL against strain D6, and 1.0 μg/mL and 1.8 μg/mL against strain W2, respectively [141] .
Recently, Frölich et al. [139] tested the in vitro antiplasmodial activity of XN as well as seven natural or semi-synthetic derivatives from hops against the chloroquine-sensitive strain poW and the multiresistant clone Dd2 using a [ 3 H]hypoxanthineincorporation assay. In addition, the influence of the compounds on GSH-dependent haemin degradation was studied in order to determine its contribution to the antimalarial effect of chalcones. In this study, XN was the most active chalcone with IC 50 values of 8.2 ± 0.3 μm (poW) and 24.0 ± 0.8 μm (Dd2). For comparison, chloroquine was tested as a positive control, and the IC 50 values obtained were 0.015 ± 0.002 μM (poW) and 0.14 ± 0.01 μM (Dd2).
This study also verified the relationship between the structure of the chalcones and the antiplasmodial activity. Indeed, the presence of the double bond in the prenyl side chain is irrelevant for the bioactivity, since XN and its 2'',3''-dihydro derivative (12.9 ± 0.6 μM for poW and 17.4 ± 0.6 μM for Dd2) had nearly identical inhibitory potencies [139] .
Compared with XN, desmethylxanthohumol (DMX), which only differs by the lack of the methyl residue at position C6', is four to five times less active. The authors suggested that this might be due to its higher hydrophilicity, hindering the entrance of the compound to the site of action inside the parasite [139] . In addition, semi-synthetic methylation of XN completely eliminated the inhibitory potential [139] . These results demonstrated for the first time the ability of chalcone derivatives to interfere with the haemin-degradation process of the malarial pathogen P. falciparum. This effect might contribute to their antiplasmodial activity. However, as one compound showed inhibition of P. falciparum without being able to interact with GSH-mediated haemin degradation, the authors suggested that other modes of action must contribute to the observed antiparasitic activity of hop chalcones [139] .
Antifungal activity:
Investigations on antifungal activity of hop constituents are limited. Mizobuchi and Sato [138] studied several hop components, including XN, against five human pathogenic fungi (Trichophyton mentagrophytes, Trichophyton rubrum, Candida albicans, Fusarium oxysporum, and Mucor rouxianus). In this study, XN and 6-prenylnaringenin (6-PN) were the most potent. With a minimum inhibitory concentration (MIC) of 3.13 μg/mL, both compounds inhibited the growth of the fungi Trichophyton mentagrophytes and Trichophyton rubrum more efficiently than the positive control griseofulvin (MIC: 6.25 μg/mL). Weak inhibition of Mucor rouxianus was also observed with XN (MIC: 50 μg/mL) [138] .
Antibacterial activity:
As more types of bacteria develop resistance to many antibiotics, there is an urgent need for new antimicrobials to which these resistant bacteria are sensitive [128] . Indeed, the antibacterial activity of hop resins and chalcones is being increasingly documented [5, 117] . Many research groups either isolated and identified the structure of chalcones that possess antibacterial activity, or synthesized or modified natural chalcones.
Dental plaque and caries are primarily caused by the bacterium Streptococcus mutans. Efforts have been underway to reduce the occurrence of dental plaque and caries with an antimicrobial agent that is not linked with undesirable side effects and/or the development of antibiotic resistance. It is recognized that some components of hop plant (Humulus lupulus L.) have bacteriostatic antimicrobial activity [130] . In fact, the hop resins also help to preserve the beer because of their antimicrobial properties. Bhattacharya et al. [130] compared the antimicrobial activities of several hop components (β-acid, XN, iso-α-acid, and tetra iso-α-acid) against four strains of S. mutans and one strain each of S. salivarius and S. sanguis with those of some essential oils used in commercially available mouthwashes (thymol, cinnamon oil, oil of clove, nerol, citral, eucalyptol, and methanol). In this study, the disc diffusion assay and the fluid turbidity assay, two complementary assays, were used to evaluate the antimicrobial activities of the compounds against the several strains. The minimum inhibitory concentration (MIC) (i.e, the lowest concentration of the test substance that shows no bacterial growth) for each test compound was determined with a turbidity assay. All tested hop constituents showed antimicrobial activity against S. mutans, S. salivarius and S. sanguis. At a dose of 50 μg per disc, XN (140 nmol) produced similar zones of inhibition against all three strains as thymol (333 nmol). On the other hand, there was no antimicrobial activity enhancement by ascorbic acid over and above the enhancement due to pH lowering [130] . However, before these hop constituents can be successfully used in oral applications (e.g., mouthwashes), their bitter taste will need to be masked or they will be unacceptable to consumers.
Very recently Natarajan et al. [128] investigated the co-action of hop-derived antibacterial compounds, lupulone (β-acid), humulone (α-acid) and XN, with several antibiotics. A positive co-action of lupulone and XN with the antibiotics polymyxin B sulfate, tobramycine and ciprofloxacin in inhibiting Grampositive and some Gram-negative bacteria has been demonstrated in in vitro experiments. The disc diffusion assay and the MIC assay were employed to determine co-action. In spite of the distinct mechanism of antibacterial effect of the three antibiotics, the authors speculated that the changes in permeability caused by the hop compounds will overcome the resistance of the bacterial membrane to the permeation of the antibiotic. In this study, a practical application of the synergistic combinations was also attempted in the form of an antibiotic cream model: Neosporin (Pfizer Inc), which contains lupulone, neomycin and polymyxin B sulfate. This cream also showed co-action [128] .
Although a number of health effects are attributed to prenylflavonoids, only a few reports are available about the bioavailability of these compounds and the transformation potency of the intestinal microbial community. Recent in vivo investigations on bioavailability of XN in rats demonstrated that XN is poorly absorbed after oral administration [131] and only a minor fraction of this compound is metabolized in the gastrointestinal tract [132] . Similar results were obtained by Possemiers et al. [133] . In this study four human fecal samples were incubated with 25 mg/L of XN, IXN and 8-PN for a period of 8 days. XN proved to be relatively stable with a recovery of above 65%. The rest were composed of small amounts of different metabolites including some IXN [133] .
Consequently, high ingestion of XN results in significant concentrations of intact XN in the gut, which in turn can influence the growth of intestinal bacteria by its antibacterial activity. Accordingly, Hanske et al. [129] investigated whether XN might influence the composition of the intestinal microbiota. With this aim, 100 mg XN/kg body weight was given daily to rats for 4 weeks. The diversity of the fecal microbial community was analyzed using PCR-DGGE. It was verified that, although XN was present in the large intestine, no impact on the composition of the rat fecal microbiota by XN could be observed. It may be concluded that oral intake of XN-containing herbal preparations is likely to have no major impacts on the microbial composition in the intestine. Based on this discovery, the authors suggested that the reported antibacterial properties of XN appear to be selectively useful against opportunistic pathogens [129] .
Antiviral activity: Viral diseases, including viral respiratory diseases, herpes virus infections, and
in particular retroviral infections (e.g. HIV-1), are an increasing worldwide health concern. It is widely documented that the efficacy of most antiviral agents is limited by the intrinsic toxicity of the compounds and the appearance of drug resistant virus following their continued use [134, 137] . As a consequence, the discovery of novel antiviral agents has gained increasing importance.
Acquired immunodeficiency (AIDS), caused by the human immunodeficiency virus (HIV), has been a life threatening health problem since 1980. Due to their structural diversity, flavonoids have been investigated for their anti-HIV activity. In a recent study realized by Wang et al. [134] , the potential of XN to inhibit various steps essential for the replication of HIV-1 was tested. It was verified that XN inhibited HIV-1 induced cytopathic effects (CPE), as well as the production of viral p24 antigen and reverse transcriptase in C8166 lymphocytes at non-cytotoxic concentration. The EC 50 values were 0.82, 1.28 and 0.50 μg/mL, respectively. XN also inhibited HIV-1 replication in peripheral blood mononuclear cells (PBMC) infected with HIV-1, with EC 50 value of 20.74 μg/mL. The activity of recombinant HIV-1 reverse transcriptase and HIV-1 entry into cells were not inhibited by XN [134] . The results obtained from this study suggested that XN is effective against HIV-1 and might serve as an interesting lead compound. It may represent a novel chemotherapeutic agent against HIV-1 infection. However, when Buckwold et al. [137] examined a XN-enriched hop extract (8.4% XN), no anti-HIV-1 activity was detected, but weak to moderate antiviral activity against bovine viral diarrhea (BVDV), herpes viruses type 1 (HSV-1) and type 2 (HSV-2), and rhinovirus (Rhino) was observed. The XN alone appeared to account for all of the antiviral activity of the XN-enriched hop extract, since the therapeutic indices (TI) of XN against BVDV, HSV-1 and HSV-2 were similar to those of the XN-enriched extract. XN also showed antiviral activity against cytomegalovirus (CMV), suggesting that it might have a generalized anti-herpesvirus antiviral activity. In summary, this chalcone might serve as an interesting lead compound against several virus infections.
Antiproliferative/anticarcinogenic activity:
Beer is a essentially safe with respect to a sanitary point of view due to easy control of the raw materials used, and to the intense thermal treatment to which they are submitted through the brewing process. In recent years there have been several studies about the presence and occurrence of toxic and allergenic substances in this beverage. Beer, being produced from cereals, can suffer some contamination with ochratoxins, which are teratogenic, immunotoxic, genotoxic, mutagenic and carcinogenic, as well as nitrosamines, nitrates, nitrites, pesticides, herbicides, and heavy metals, all recognized as carcinogenic substances [75] . However, the levels of all these substances in beer are very low (< μg/Kg) and are unlikely to constitute a hazard for moderate beer drinkers [75] . On the other hand, several compounds (e.g. XN, fibre, vitamins), which are present in beer at higher concentrations than those contaminants are being studied for their chemoprotective and Table 4 : In vitro biological activities of prenylflavonoids as potential cancer chemopreventive agents.
Legend: XN, xanthohumol; DX, dehydrocycloxanthohumol; IXN, isoxanthohumol; DMX, desmethylxanthohumol; 6-PN, 6-prenylnaringenin; 8-PN, 8prenylnaringenin anticarcinogenic activities. Over the past 10 years several in vitro and in vivo studies have evaluated the potential activity of hop components, especially XN, as chemopreventive agents. However, in vivo studies are still very limited. XN possesses a large spectrum of chemopreventive mechanisms in a wide variety of cancer cell lines, such as breast, colon, ovarian, and prostate [3, 4, 103, 107, 114] . XN has shown an exceptionally broad spectrum of inhibitory mechanisms at the initiation (reactive molecules, DNA damage), promotion (mutation, changed cell structure), and progression (uncontrolled cell growth, tumors, metastases) stages of carcinogenesis [3] ; studies on the mechanism of action of this molecule are on the increase [93] .
At the initiation stage of carcinogenesis, XN potently modulates the activity of the cytochrome P450s enzymes involved in the metabolic activation of procarcinogens [3, [110] [111] [112] . Moreover, XN induces NAD(P)H; quinone reductase activity, which regulates detoxification [3, 108, 110, 113] . As a potential anti-tumor-promoting mechanism, XN has anti-inflammatory properties by inhibiting the activity of cyclooxygenase-1 and cyclooxygenase-2 as well as the production of nitric oxide [3, 109] . The antiproliferative mechanisms of XN preventing carcinogenesis in the progression phase include the inhibition of DNA synthesis and the induction of the cell cycle arrest in the S phase, apoptosis, and terminal cell differentiation [3, 114] . XN has also been reported to be a strong inhibitor of angiogenesis, which is essential for solid tumor growth and dissemination [123, 127] . Some of the more recent and important data with respect to health benefits or biological activities in vitro of prenylflavonoids from hops are briefly presented in Table 4 .
The first in vivo evidence of a cancer-inhibiting effect was provided by cancer researchers in Heidelberg [4] who treated mice with breast cancer with XN for two weeks. Compared to control animals, tumor growth decreased by 83%. Inhibition of the formation of new blood vessels (angiogenesis) was determined to be a possible cause of the effectiveness [4] . A recent study performed in vivo that XN administered in t drinking water at the concentration of 2 μm induced a significant inhibition of angiogenesis in mice implanted with a matrigel sponge. At a higher concentration (200 μm) XN displayed a marked angiogenesis inhibition without adverse effects on animal health parameters [123] . In the same investigation, the oral administration of XN (20 μM) significantly inhibited the growth rate of KS-IMM tumors (Kaposi's sarcoma cell line) in male nude mice, starting from the 20 th day of treatment. This "angio-prevention" by XN is a promising new approach in cancer research also confirmed in animal tests at the Institute for Clinical and Biological Sciences of the University of Varese in Italy [126] .
